Teva Picked as Bellwether Target in Generic Drug Price-Fix Case

Teva Pharmaceutical Industries Ltd. will be the focus of the first trial over an alleged “overarching” industrywide conspiracy to fix generic prices, while bellwether trials involving schemes to fix three specific drug prices will advance along a separate track, a federal judge in Philadelphia ruled Tuesday.

The procedure will test the case’s fitness for class action treatment “as to several individual drug conspiracies, and also explore the merits of an overarching conspiracy case,” Judge Cynthia M. Rufe wrote. “This is a balanced approach that takes into consideration the different types of cases in the MDL.”

The sprawling multidistrict lawsuit, consolidated ...